Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '25 Jul 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	4,119	3,091	-	-	-	-
Enterprise Value	6,830	5,444	-	-	-	-
Last Close Price	167.15	125.45	-	-	-	-
PE Ratio	10.47	9.08	-	-	-	-
PS Ratio	0.93	0.70	-	-	-	-
PB Ratio	2.50	1.87	-	-	-	-
P/TBV Ratio	2.50	1.88	-	-	-	-
P/OCF Ratio	10.32	7.75	-	-	-	-
EV/Sales Ratio	1.54	1.23	-	-	-	-
EV/EBITDA Ratio	5.74	4.58	-	-	-	-
EV/EBIT Ratio	10.68	8.51	-	-	-	-
Debt / Equity Ratio	1.69	1.69	11.23	5.05	5.20	5.86
Debt / EBITDA Ratio	2.34	2.34	3.21	2.69	3.77	3.40
Debt / FCF Ratio	-	-	-	49.69	-	-
Asset Turnover	1.01	1.01	1.09	1.58	1.65	-
Inventory Turnover	7.63	7.63	10.91	20.62	20.46	-
Quick Ratio	0.91	0.91	0.75	0.46	0.61	0.67
Current Ratio	1.37	1.37	1.04	0.63	0.87	0.86
Return on Equity (ROE)	36.12%	36.12%	99.69%	33.32%	45.29%	-
Return on Assets (ROA)	9.07%	9.07%	8.22%	6.20%	4.45%	-
Return on Capital (ROIC)	10.93%	10.93%	10.66%	8.38%	6.00%	-
Return on Capital Employed (ROCE)	18.30%	18.30%	19.60%	18.50%	11.80%	14.90%
Earnings Yield	8.27%	11.02%	-	-	-	-
FCF Yield	-27.53%	-36.68%	-	-	-	-
Buyback Yield / Dilution	-23.25%	-23.25%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.